Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Penack

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
Frontiers in Immunology|October 26, 2019
Acute Graft-vs.-Host Disease-Associated Endothelial Activation <i>in vitro</i> Is Prevented by DefibrotideJulia Martinez-Sanchez, Hannah Hamelmann, Marta Palomo, et al.
Frontiers in Immunology|August 28, 2020
Reduced Calcium Signaling Is Associated With Severe Graft-Versus-Host Disease: Results From Preclinical Models and From a Prospective EBMT StudyKatarina Riesner, Steffen Cordes, Christophe Peczynski, et al.
Blood|January 19, 2017
Initiation of acute graft-versus-host disease by angiogenesisKatarina Riesner, Yu Shi, Angela Jacobi, et al.
Journal for Immunotherapy of Cancer|March 21, 2025
Leucine-rich α-2 glycoprotein 1 (LRG1) during inflammatory complications after allogeneic stem cell transplantation and CAR-T cell therapySarah Mertlitz, Katarina Riesner, Martina Kalupa, et al.
Frontiers in Immunology|April 17, 2020
Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)Robert David Sandler, Rachel Scarlett Tattersall, Helene Schoemans, et al.
Blood Advances|January 5, 2024
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortalityKai Rejeski, Yucai Wang, Doris K Hansen, et al.
Frontiers in Immunology|May 19, 2023
Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantationMarie Luise Hütter-Krönke, Adela Neagoie, Igor Wolfgang Blau, et al.
Leukemia|June 25, 2024
How risky is a second allogeneic stem cell transplantation?Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Blood|January 19, 2013
Inflammatory neovascularization during graft-versus-host disease is regulated by αv integrin and miR-100Franziska Leonhardt, Sebastian Grundmann, Martin Behe, et al.
Blood Cancer Journal|March 15, 2024
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantationOlaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
Frontiers in Immunology|October 26, 2019
Acute Graft-vs.-Host Disease-Associated Endothelial Activation <i>in vitro</i> Is Prevented by DefibrotideJulia Martinez-Sanchez, Hannah Hamelmann, Marta Palomo, et al.
Frontiers in Immunology|August 28, 2020
Reduced Calcium Signaling Is Associated With Severe Graft-Versus-Host Disease: Results From Preclinical Models and From a Prospective EBMT StudyKatarina Riesner, Steffen Cordes, Christophe Peczynski, et al.
Blood|January 19, 2017
Initiation of acute graft-versus-host disease by angiogenesisKatarina Riesner, Yu Shi, Angela Jacobi, et al.
Journal for Immunotherapy of Cancer|March 21, 2025
Leucine-rich α-2 glycoprotein 1 (LRG1) during inflammatory complications after allogeneic stem cell transplantation and CAR-T cell therapySarah Mertlitz, Katarina Riesner, Martina Kalupa, et al.
Frontiers in Immunology|April 17, 2020
Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)Robert David Sandler, Rachel Scarlett Tattersall, Helene Schoemans, et al.
Blood Advances|January 5, 2024
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortalityKai Rejeski, Yucai Wang, Doris K Hansen, et al.
Frontiers in Immunology|May 19, 2023
Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantationMarie Luise Hütter-Krönke, Adela Neagoie, Igor Wolfgang Blau, et al.
Leukemia|June 25, 2024
How risky is a second allogeneic stem cell transplantation?Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Blood|January 19, 2013
Inflammatory neovascularization during graft-versus-host disease is regulated by αv integrin and miR-100Franziska Leonhardt, Sebastian Grundmann, Martin Behe, et al.
Blood Cancer Journal|March 15, 2024
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantationOlaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Pageof 19